MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)
MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)
Recruiting · NCT07479485 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II) | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-07-28 | NCT07479485 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lepu Biopharma Co., Ltd. | 15 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing You An Hospital, Capital Medical University | Beijing | China | 1 |
| Henan Cancer Hospital | Zhengzhou | China | 57 |
| Lishui Central Hospital | Lishui | China | 15 |
| Mengchao Hepatobiliary Hospital of Fujian Medical University | Fuzhou | China | 3 |
| Peking Union Medical College Hospital | Beijing | China | 201 |
| The Ethics Committee of Cancer Hospital Chinese Academy of Medical Sciences. | Beijing | China | 1 |
| The First Affiliated Hospital With Nanjing Medical University | Nanjing | China | 1 |
| Tianjin Cancer Hospital Airport Hospital | Tianjin | China | 18 |